NEW SHARE CAPITAL INCREASE REGISTERED
27.10.2020
MANDATORY NOTIFICATION OF TRADE
21.10.2020
NOTICE OF EXTRAORDINARY GENERAL MEETING
HBC RECEIVES APPROVAL FROM HEALTH CANADA FOR QUALIFIED HEALTH CLAIMS FOCUSED ON MAINTAINING HEALTHY LEVELS OF FERRITIN AND HEMOGLOBIN AND THE BLOOD COMPONENTS REQUIRED FOR OXYGEN TRANSPORT
19.10.2020
Disclosure of large shareholding
16.10.2020
KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING
PRIVATE PLACEMENT SUCCESSFULLY PLACED
CONTEMPLATED PRIVATE PLACEMENT – INTENDED TRANSFER OF LISTING TO OSLO BØRS
15.10.2020
PROGO’s BIOACTIVE PEPTIDES TO SUPPORT HEALTHY IRON LEVELS TO BE LAUNCHED IN THE U.S.
13.10.2020
HBC’S APPLICATION TO HEALTH CANADA FOR UNIQUE QUALIFIED HEALTH CLAIMS IS PROGRESSING VERY WELL AND A POSITIVE CONCLUSION IS EXPECTED DURING OCTOBER 2020
06.10.2020